SIMILAR PATTERNS OF AMINO ACIDS FOR 2BFM_B_TOPB1290_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1p33 | PTERIDINE REDUCTASE1 (Leishmaniatarentolae) |
PF13561(adh_short_C2) | 6 | PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226 | MTX A 351 (-3.5A)NDP A 300 ( 3.7A)MTX A 351 (-4.5A)MTX A 351 (-4.8A)MTX A 351 ( 4.4A)MTX A 351 ( 4.4A) | 0.23A | 2bfmB-1p33A:43.82bfmC-1p33A:43.3 | 2bfmB-1p33A:80.622bfmC-1p33A:80.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1p33 | PTERIDINE REDUCTASE1 (Leishmaniatarentolae) |
PF13561(adh_short_C2) | 6 | PHE A 113ASP A 181TYR A 191TYR A 194LEU A 226LEU A 229 | MTX A 351 (-3.5A)NDP A 300 ( 3.7A)MTX A 351 (-4.8A)MTX A 351 ( 4.4A)MTX A 351 ( 4.4A)MTX A 351 (-4.9A) | 0.69A | 2bfmB-1p33A:43.82bfmC-1p33A:43.3 | 2bfmB-1p33A:80.622bfmC-1p33A:80.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1p33 | PTERIDINE REDUCTASE1 (Leishmaniatarentolae) |
PF13561(adh_short_C2) | 5 | PHE A 113LEU A 188TYR A 191TYR A 194LEU A 226 | MTX A 351 (-3.5A)MTX A 351 (-4.5A)MTX A 351 (-4.8A)MTX A 351 ( 4.4A)MTX A 351 ( 4.4A) | 0.95A | 2bfmB-1p33A:43.82bfmC-1p33A:43.3 | 2bfmB-1p33A:80.622bfmC-1p33A:80.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uch | UBIQUITIN C-TERMINALHYDROLASE UCH-L3 (Homo sapiens) |
PF01088(Peptidase_C12) | 5 | PHE A 122LEU A 138TYR A 137LEU A 23ARG A 5 | None | 1.11A | 2bfmB-1uchA:0.02bfmC-1uchA:0.0 | 2bfmB-1uchA:22.042bfmC-1uchA:22.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) |
PF00106(adh_short)PF13561(adh_short_C2) | 8 | PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229HIS A 241 | FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)NoneFE1 A1301 (-4.2A) | 0.42A | 2bfmB-2qhxA:45.72bfmC-2qhxA:44.7 | 2bfmB-2qhxA:87.802bfmC-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) |
PF00106(adh_short)PF13561(adh_short_C2) | 6 | PHE A 113LEU A 188TYR A 191TYR A 194LEU A 226HIS A 241 | FE1 A1301 (-3.4A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)FE1 A1301 (-4.2A) | 1.34A | 2bfmB-2qhxA:45.72bfmC-2qhxA:44.7 | 2bfmB-2qhxA:87.802bfmC-2qhxA:87.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k8k | ALPHA-AMYLASE, SUSG (Bacteroidesthetaiotaomicron) |
PF00128(Alpha-amylase) | 5 | PHE A 405TYR A 367TYR A 355LEU A 387LEU A 446 | None | 1.32A | 2bfmB-3k8kA:1.82bfmC-3k8kA:0.2 | 2bfmB-3k8kA:18.142bfmC-3k8kA:18.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4psw | HISTONEACETYLTRANSFERASETYPE B CATALYTICSUBUNITHISTONEACETYLTRANSFERASETYPE B SUBUNIT 2 (Saccharomycescerevisiae) |
PF00400(WD40)PF00583(Acetyltransf_1)PF10394(Hat1_N)PF12265(CAF1C_H4-bd) | 5 | PHE A 205LEU B 288TYR A 199LEU B 267LEU B 281 | None | 1.31A | 2bfmB-4pswA:0.02bfmC-4pswA:0.0 | 2bfmB-4pswA:20.122bfmC-4pswA:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r7p | UTP--GLUCOSE-1-PHOSPHATEURIDYLYLTRANSFERASE (Homo sapiens) |
PF01704(UDPGP) | 5 | PHE A 446LEU A 432TYR A 442LEU A 455LEU A 472 | None | 1.16A | 2bfmB-4r7pA:1.72bfmC-4r7pA:1.6 | 2bfmB-4r7pA:19.922bfmC-4r7pA:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4v39 | SIALYLTRANSFERASE (Pasteurelladagmatis) |
PF11477(PM0188) | 5 | PHE A 172LEU A 191TYR A 170LEU A 184LEU A 122 | None | 1.28A | 2bfmB-4v39A:5.02bfmC-4v39A:5.7 | 2bfmB-4v39A:19.392bfmC-4v39A:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c66 | CRISPR-ASSOCIATEDPROTEIN, CSE1 FAMILY (Thermobifidafusca) |
no annotation | 5 | PHE A 248LEU A 254LEU A 138LEU A 281ARG A 137 | None | 1.38A | 2bfmB-6c66A:0.02bfmC-6c66A:0.0 | 2bfmB-6c66A:14.482bfmC-6c66A:14.48 |